Neurimmune AG
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM (NCT07213583) | Neurimmune AG | 2025-08-28 |
| First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy (NCT04360434) | Neurimmune AG | 2020-02-10 |
Track Neurimmune AG automatically
Every clearance here is in the API, with alerts when new ones post.